64 related articles for article (PubMed ID: 8941324)
1. Characterization of the protein product encoded by a splicing variant of the Marek's disease virus Eco-Q gene (Meq).
Peng Q; Shirazi Y
Virology; 1996 Dec; 226(1):77-82. PubMed ID: 8941324
[TBL] [Abstract][Full Text] [Related]
2. MEQ and V-IL8: cellular genes in disguise?
Liu JL; Lin SF; Xia L; Brunovskis P; Li D; Davidson I; Lee LF; Kung HJ
Acta Virol; 1999; 43(2-3):94-101. PubMed ID: 10696427
[TBL] [Abstract][Full Text] [Related]
3. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
4. Transactivation activity of Meq, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells.
Qian Z; Brunovskis P; Rauscher F; Lee L; Kung HJ
J Virol; 1995 Jul; 69(7):4037-44. PubMed ID: 7769661
[TBL] [Abstract][Full Text] [Related]
5. Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style.
Liu JL; Kung HJ
Virus Genes; 2000; 21(1-2):51-64. PubMed ID: 11022789
[TBL] [Abstract][Full Text] [Related]
6. Nuclear localization and dynamic properties of the Marek's disease virus oncogene products Meq and Meq/vIL8.
Anobile JM; Arumugaswami V; Downs D; Czymmek K; Parcells M; Schmidt CJ
J Virol; 2006 Feb; 80(3):1160-6. PubMed ID: 16414993
[TBL] [Abstract][Full Text] [Related]
7. Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites.
Ramirez-Carrozzi VR; Kerppola TK
J Mol Biol; 2001 Jan; 305(3):411-27. PubMed ID: 11152600
[TBL] [Abstract][Full Text] [Related]
8. Both homo and heterodimers of Marek's disease virus encoded Meq protein contribute to transformation of lymphocytes in chickens.
Suchodolski PF; Izumiya Y; Lupiani B; Ajithdoss DK; Lee LF; Kung HJ; Reddy SM
Virology; 2010 Apr; 399(2):312-21. PubMed ID: 20137800
[TBL] [Abstract][Full Text] [Related]
9. Isolation and characterization of Marek's disease virus (MDV) cDNAs from a MDV-transformed lymphoblastoid cell line: identification of an open reading frame antisense to the MDV Eco-Q protein (Meq).
Peng Q; Shirazi Y
Virology; 1996 Jul; 221(2):368-74. PubMed ID: 8661449
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells.
Levy AM; Izumiya Y; Brunovskis P; Xia L; Parcells MS; Reddy SM; Lee L; Chen HW; Kung HJ
J Virol; 2003 Dec; 77(23):12841-51. PubMed ID: 14610205
[TBL] [Abstract][Full Text] [Related]
11. Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ.
Liu JL; Lee LF; Ye Y; Qian Z; Kung HJ
J Virol; 1997 Apr; 71(4):3188-96. PubMed ID: 9060682
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a nuclear factor that binds juxtaposed with ATF3/Jun on a composite response element specifically mediating induced transcription in response to an epidermal growth factor/Ras/Raf signaling pathway.
Nilsson M; Ford J; Bohm S; Toftgård R
Cell Growth Differ; 1997 Aug; 8(8):913-20. PubMed ID: 9269900
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
14. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
Chang CH; Scott GK; Baldwin MA; Benz CC
Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
[TBL] [Abstract][Full Text] [Related]
15. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
17. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
18. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
19. Marek's disease virus latent protein MEQ: delineation of an epitope in the BR1 domain involved in nuclear localization.
Lee LF; Liu JL; Cui XP; Kung HJ
Virus Genes; 2003 Dec; 27(3):211-8. PubMed ID: 14618081
[TBL] [Abstract][Full Text] [Related]
20. Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein.
Qian Z; Brunovskis P; Lee L; Vogt PK; Kung HJ
J Virol; 1996 Oct; 70(10):7161-70. PubMed ID: 8794363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
